More on MESO
Data
Upcoming Events
News
|
|||||
|---|---|---|---|---|---|
| Prev. Close | $14.93 |
|
|||
| Open | $14.93 | ||||
| 52 Wk High | $10.89 | ||||
| 52 Wk Low | $3.50 | ||||
| Day High | $14.93 | ||||
| Day Low | $14.93 | ||||
| P/E | N/A | ||||
| EPS | $0.00 | ||||
| Volume | 10 | ||||
- Form 3 MESOBLAST LTD For: Mar 18 Filed by: COBLEY LYNETTE ELIZABETH
- Mesoblast completes patient recruitment for phase 3 chronic back pain trial
- Mesoblast Achieves Patient Recruitment Target in Pivotal Phase 3 Trial for Chronic Low Back Pain
- Mesoblast acquires CAR platform technology to enhance cell therapies
- Mesoblast Acquires Chimeric Antigen Receptor (CAR) Platform Technology for Precision-Enhanced Cell Products
- Form 4 MESOBLAST LTD For: Apr 09 Filed by: George Gregory
- Form 4 MESOBLAST LTD For: Apr 09 Filed by: George Gregory
- Mesoblast receives FDA clearance for Duchenne muscular dystrophy trial
- Mesoblast Receives IND Clearance From FDA to Directly Proceed to Registrational Trial for Approval of Ryoncil® in Duchenne Muscular Dystrophy - CORRECTION
- Mesoblast R&D Day Features Significant Commercial Progress & Platform Innovation
Entities mentioned with MESO
- FDA | View Related Stories »
- Twitter | View Related Stories »
- Earnings | View Related Stories »
- AdCom | View Related Stories »
- PDUFA | View Related Stories »
- Definitive Agreement | View Related Stories »
- Pre Market Movers | View Related Stories »
- Carl Icahn | View Related Stories »
- Show More...
